Monaco Asset Management SAM
- SEC CIK
- 0001803593
- Latest filing
- Aug 7, 2026
VNDA holding history
Vanda Pharmaceuticals Inc. in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VNDA overviewAll 13F holders of VNDAFull Q2 2026 holdings
- Shares (Q2 2026)
- 221,286
- Value
- $1.35M
- % of portfolio
- 0.5%
- Quarters held
- 11
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 221,286 | $1.35M | 0.5% | −20,000−8.3% | Reduced | Holders |
| Q1 2026 | 241,286 | $1.67M | 0.5% | +45,000+22.9% | Added | Holders |
| Q4 2025 | 196,286 | $1.73M | 0.5% | −51,519−20.8% | Reduced | Holders |
| Q3 2025 | 247,805 | $1.24M | 0.5% | −57,195−18.8% | Reduced | Holders |
| Q2 2025 | 305,000 | $1.44M | 0.5% | −20,000−6.2% | Reduced | Holders |
| Q1 2025 | 325,000 | $1.49M | 0.8% | −67,262−17.1% | Reduced | Holders |
| Q4 2024 | 392,262 | $1.88M | 0.8% | +188,836+92.8% | Added | Holders |
| Q3 2024 | 203,426 | $954.1K | 0.4% | +10,500+5.4% | Added | Holders |
| Q2 2024 | 192,926 | $1.09M | 0.5% | +192,926 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −85,000−100.0% | Sold out | Holders |
| Q4 2023 | 85,000 | $358.7K | 0.1% | −50,000−37.0% | Reduced | Holders |
| Q3 2023 | 135,000 | $583.2K | 0.3% | +135,000 | New | Holders |